Novartis India Limited (NSE:NOVARTIND)
1,050.70
+14.10 (1.36%)
May 6, 2026, 3:29 PM IST
Novartis India Company Description
Novartis India Limited is involved in the pharmaceutical business in India.
The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands.
It also offers neuroscience products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is headquartered in Mumbai, India.
Novartis India Limited operates as a subsidiary of Novartis AG.
Novartis India Limited
| Country | India |
| Founded | 1947 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 56 |
Contact Details
Address: Inspire BKC Mumbai, 400051 India | |
| Phone | 91 22 50243000 |
| Website | novartis.in |
Stock Details
| Ticker Symbol | NOVARTIND |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE234A01025 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Vasant Narasimhan | Chief Executive Officer of Novartis |
| Sanjay Prabhakar Murdeshwar | MD and Vice Chairman |
| Shilpa Joshi | Chief Financial Officer and Whole-Time Director |
| Nikhil Malpani | Company Secretary and Compliance Officer |
| N. Kumar | Country Head of Ethics, Risk and Compliance |